XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative and Other Financial Instruments - Narrative (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]        
Objective for using derivative instruments The Company’s objective in managing exposure to market and interest rate risk is to limit the impact on earnings and cash flow.      
Loss expected to be reclassified to earnings $ (5)      
Loss, net of tax, expected to be reclassified to earnings (4)      
Reclassification of anticipated transactions that were no longer considered probable 0 $ 0    
Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax 41 (16)    
Gain (loss) on net investment hedge settlements, net of tax 34 (14)    
Reduction in interest expense 6 6    
Cumulative amount of fair value hedging adjustment included in the carrying about of the hedged assets (1)     $ 2
Hedged liability, fair value hedge, cumulative increase (decrease) (1)     2
Accumulated Other Comprehensive Gain        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain on net investment hedge settlements 90     49
Gain on net investment hedge settlements, net of tax 102     $ 68
Derivatives Designated as Net Investment Hedges        
Derivative Instruments, Gain (Loss) [Line Items]        
Carrying amount of hedged net investment 1,758   € 1,629  
Foreign Exchange        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain (loss) from foreign exchange contracts designated as fair value hedges (less than) 4 $ (5)    
Cross Currency Interest Rate Contract        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, notional amount $ 875      
Minimum        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, remaining maturity range (in months) 1 month   1 month  
Maximum        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, remaining maturity range (in months) 33 months   33 months